Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy.
J Hematol Oncol
; 9(1): 96, 2016 Sep 23.
Article
in En
| MEDLINE
| ID: mdl-27663515
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
J Hematol Oncol
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2016
Type:
Article
Affiliation country:
United States